Culture-enriched human gut microbiomes reveal core and accessory resistance genes.


Journal

Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147

Informations de publication

Date de publication:
05 04 2019
Historique:
received: 11 12 2018
accepted: 20 03 2019
entrez: 7 4 2019
pubmed: 7 4 2019
medline: 21 6 2019
Statut: epublish

Résumé

Low-abundance microorganisms of the gut microbiome are often referred to as a reservoir for antibiotic resistance genes. Unfortunately, these less-abundant bacteria can be overlooked by deep shotgun sequencing. In addition, it is a challenge to associate the presence of resistance genes with their risk of acquisition by pathogens. In this study, we used liquid culture enrichment of stools to assemble the genome of lower-abundance bacteria from fecal samples. We then investigated the gene content recovered from these culture-enriched and culture-independent metagenomes in relation with their taxonomic origin, specifically antibiotic resistance genes. We finally used a pangenome approach to associate resistance genes with the core or accessory genome of Enterobacteriaceae and inferred their propensity to horizontal gene transfer. Using culture-enrichment approaches with stools allowed assembly of 187 bacterial species with an assembly size greater than 1 million nucleotides. Of these, 67 were found only in culture-enriched conditions, and 22 only in culture-independent microbiomes. These assembled metagenomes allowed the evaluation of the gene content of specific subcommunities of the gut microbiome. We observed that differentially distributed metabolic enzymes were associated with specific culture conditions and, for the most part, with specific taxa. Gene content differences between microbiomes, for example, antibiotic resistance, were for the most part not associated with metabolic enzymes, but with other functions. We used a pangenome approach to determine if the resistance genes found in Enterobacteriaceae, specifically E. cloacae or E. coli, were part of the core genome or of the accessory genome of this species. In our healthy volunteer cohort, we found that E. cloacae contigs harbored resistance genes that were part of the core genome of the species, while E. coli had a large accessory resistome proximal to mobile elements. Liquid culture of stools contributed to an improved functional and comparative genomics study of less-abundant gut bacteria, specifically those associated with antibiotic resistance. Defining whether a gene is part of the core genome of a species helped in interpreting the genomes recovered from culture-independent or culture-enriched microbiomes.

Sections du résumé

BACKGROUND
Low-abundance microorganisms of the gut microbiome are often referred to as a reservoir for antibiotic resistance genes. Unfortunately, these less-abundant bacteria can be overlooked by deep shotgun sequencing. In addition, it is a challenge to associate the presence of resistance genes with their risk of acquisition by pathogens. In this study, we used liquid culture enrichment of stools to assemble the genome of lower-abundance bacteria from fecal samples. We then investigated the gene content recovered from these culture-enriched and culture-independent metagenomes in relation with their taxonomic origin, specifically antibiotic resistance genes. We finally used a pangenome approach to associate resistance genes with the core or accessory genome of Enterobacteriaceae and inferred their propensity to horizontal gene transfer.
RESULTS
Using culture-enrichment approaches with stools allowed assembly of 187 bacterial species with an assembly size greater than 1 million nucleotides. Of these, 67 were found only in culture-enriched conditions, and 22 only in culture-independent microbiomes. These assembled metagenomes allowed the evaluation of the gene content of specific subcommunities of the gut microbiome. We observed that differentially distributed metabolic enzymes were associated with specific culture conditions and, for the most part, with specific taxa. Gene content differences between microbiomes, for example, antibiotic resistance, were for the most part not associated with metabolic enzymes, but with other functions. We used a pangenome approach to determine if the resistance genes found in Enterobacteriaceae, specifically E. cloacae or E. coli, were part of the core genome or of the accessory genome of this species. In our healthy volunteer cohort, we found that E. cloacae contigs harbored resistance genes that were part of the core genome of the species, while E. coli had a large accessory resistome proximal to mobile elements.
CONCLUSION
Liquid culture of stools contributed to an improved functional and comparative genomics study of less-abundant gut bacteria, specifically those associated with antibiotic resistance. Defining whether a gene is part of the core genome of a species helped in interpreting the genomes recovered from culture-independent or culture-enriched microbiomes.

Identifiants

pubmed: 30953542
doi: 10.1186/s40168-019-0669-7
pii: 10.1186/s40168-019-0669-7
pmc: PMC6451232
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

56

Références

Cell. 2018 Mar 8;172(6):1216-1227
pubmed: 29522743
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61
pubmed: 20847294
ISME J. 2014 Nov;8(11):2349-51
pubmed: 24824669
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents
pubmed: 19136439
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6252-7
pubmed: 21436049
Nat Rev Microbiol. 2011 Nov 02;9(12):894-6
pubmed: 22048738
Nat Rev Microbiol. 2015 Feb;13(2):116-23
pubmed: 25534811
Lancet. 2011 Jul 23;378(9788):369-71
pubmed: 21477855
Cell. 2013 Jan 17;152(1-2):39-50
pubmed: 23332745
Nature. 2016 May 11;533(7602):212-6
pubmed: 27172044
Cell. 2018 Mar 8;172(6):1173-1177
pubmed: 29522739
Nat Microbiol. 2016 Nov 07;1:16203
pubmed: 27819657
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
OMICS. 2018 Feb;22(2):108-118
pubmed: 28402209
J Clin Microbiol. 1995 Sep;33(9):2505-7
pubmed: 7494061
Antimicrob Resist Infect Control. 2012 Nov 27;1(1):39
pubmed: 23181506
Sci Rep. 2017 Dec 1;7(1):16788
pubmed: 29196717
Nat Rev Microbiol. 2016 Jan;14(1):20-32
pubmed: 26499895
Clin Microbiol Infect. 2012 Dec;18(12):1185-93
pubmed: 23033984
Genome Med. 2016 Jul 01;8(1):72
pubmed: 27363992
Nucleic Acids Res. 2015 Jan;43(Database issue):D439-46
pubmed: 25378310
ILAR J. 2015;56(2):228-40
pubmed: 26323632
Microb Drug Resist. 2018 Jun;24(5):542-546
pubmed: 29185915
Trends Genet. 2013 Mar;29(3):170-5
pubmed: 23332119
Nature. 2016 Jul 21;535(7612):435-439
pubmed: 27409808
Trends Microbiol. 2018 Apr;26(4):296-312
pubmed: 29530606
Genome Res. 2016 Aug;26(8):1101-9
pubmed: 27432456
Nat Biotechnol. 2018 Oct 15;:
pubmed: 30320765
Microbiome. 2018 Jan 15;6(1):11
pubmed: 29335005
Nature. 2014 May 29;509(7502):612-6
pubmed: 24847883
Nature. 2017 Oct 5;550(7674):61-66
pubmed: 28953883
Antimicrob Agents Chemother. 2007 Nov;51(11):4111-7
pubmed: 17724150
Clin Microbiol Rev. 2012 Oct;25(4):661-81
pubmed: 23034325
Genome Biol. 2012 Dec 22;13(12):R122
pubmed: 23259615
Gastroenterology. 2014 Nov;147(5):1055-63.e8
pubmed: 25046162
Microbiology. 2009 Nov;155(Pt 11):3758-3774
pubmed: 19684063
Gut Microbes. 2016 Sep 2;7(5):428-34
pubmed: 27494088
Microbiome. 2015 Sep 30;3:42
pubmed: 26419531
ISME J. 2016 Mar;10(3):707-20
pubmed: 26359913
Clin Infect Dis. 2017 Aug 15;65(suppl_1):S20-S29
pubmed: 28859350
J Comput Biol. 2010 Nov;17(11):1519-33
pubmed: 20958248
Nat Rev Microbiol. 2017 Jul;15(7):422-434
pubmed: 28392565
Nat Commun. 2014 Aug 28;5:4714
pubmed: 25163406
Environ Microbiol. 2017 Nov;19(11):4771-4783
pubmed: 28967204

Auteurs

Frédéric Raymond (F)

École de nutrition, Faculté des sciences de l'agriculture et de l'alimentation, Université Laval, Québec City, Canada. frederic.raymond@fsaa.ulaval.ca.
Institut sur la nutrition et les aliments fonctionnels, Québec, Canada. frederic.raymond@fsaa.ulaval.ca.

Maurice Boissinot (M)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.

Amin Ahmed Ouameur (AA)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.

Maxime Déraspe (M)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.
Centre de recherche en données massives, Université Laval, Québec City, Canada.

Pier-Luc Plante (PL)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.
Centre de recherche en données massives, Université Laval, Québec City, Canada.

Sewagnouin Rogia Kpanou (SR)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.
Centre de recherche en données massives, Université Laval, Québec City, Canada.

Ève Bérubé (È)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.

Ann Huletsky (A)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.

Paul H Roy (PH)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.
Département de biochimie, de microbiologie et de bio-informatique, Faculté des Sciences et de Génie, Université Laval, Québec City, Canada.

Marc Ouellette (M)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.
Département de Microbiologie, Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec City, Canada.

Michel G Bergeron (MG)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.
Département de Microbiologie, Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec City, Canada.

Jacques Corbeil (J)

Centre de Recherche en Infectiologie de l'Université Laval, Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Canada.
Centre de recherche en données massives, Université Laval, Québec City, Canada.
Département de médecine moléculaire, Faculté de Médecine, Université Laval, Québec City, Canada.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH